Simavita Limited

Simavita Limited

June 30, 2015 11:37 ET

Simavita Limited: Cancellation of Options

SYDNEY, AUSTRALIA--(Marketwired - June 30, 2015) - Simavita Limited ("Simavita" or the "Company") (TSX VENTURE:SV)(ASX:SVA) reports that a total of 214,000 options that had been issued to former employees have been forfeited and have therefore now been cancelled.

The details of the cancelled options are as follows:

ASX code Number of options Exercise price Expiry date
SVAAJ 214,000 $0.70 31 August 2018

For further information, please contact the persons outlined below.

About Simavita

Simavita is a medical device company that has developed an innovative, world first solution for the management of urinary incontinence, with a focus on the elderly. The first product is the SIM™ platform technology which is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan. Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit

The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

Contact Information

  • Philippa Lewis
    Chief Executive Officer
    T: +61 2 8405 6381

    Thomas Howitt
    Chief Financial Officer
    T: +61 418 351 127

    Media and Investor Relations
    In Australia:
    Jane Lowe
    IR Department
    T: +61 411 117 774